Monday, February 02, 2026

When specialization creates exclusion: the dangers of a compartmentalized medical system


Drawing on real-world cases, the study highlights the harms of compartmentalized healthcare and proposes three essential reforms



International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo

Overcoming Medical Compartmentalization: How Integrated Care Improves Outcomes 

image: 

The study offers a real-world example of medical compartmentalization, where care is divided across specialized disciplines without coordination, and shows how comprehensive, integrated health care systems can improve overall well-being for patients.

view more 

Credit: Professor Kiyoto Kasai from the International Research Center for Neurointelligence (WPI-IRCN), University of Tokyo, Japan.





Tokyo, Japan—Over the years, medical care has become increasingly specialized, with each discipline focusing on narrower areas of expertise. While this specialization has led to major advances and improved the quality of care, it has also resulted in the compartmentalization of healthcare. Patients with multiple conditions are often required to consult several specialists, and care is delivered in fragments rather than as a whole.

In a recent study, Professor Kiyoto Kasai from the International Research Center for Neurointelligence (WPI-IRCN), along with Dr. Yousuke Kumakura from the Department of Neuropsychiatry, Graduate School of Medicine, and Dr. Shin-ichiro Kumagaya from the Research Center for Advanced Science and Technology, all at The University of Tokyo, Japan, examined the severe consequences of this fragmentation by analyzing the collective experiences of multiple patients with a genetic disorder that causes a wide range of medical, developmental, and psychiatric conditions. This analysis draws on patients seen at the 22q11 deletion syndrome Special Clinic at the University of Tokyo Hospital, as well as participants from related surveys and interviews. The study reveals how compartmentalization led to a patient being refused care, details the debilitating effects on her life, and demonstrates how interdisciplinary care ultimately led to positive outcomes. Their findings are published in Volume 406, Issue 10,517 of the journal The Lancet on November 15, 2025.

Medical compartmentalization occurs when clinicians become so entrenched in their specialty—with its own set of rules, rationality, and obligations—that they do not operate beyond their area of expertise. Our study reveals the ‘invisible mismatch’ that occurs when individuals with multiple, co-occurring disabilities, such as congenital heart disease, intellectual and developmental disabilities, and psychiatric symptoms, encounter medical systems that are organized into narrowly defined specialties,” says Prof. Kasai.

To illustrate this systemic failure, the researchers consolidated these patient experiences into a single representative case study named Cocoro, presented as a 22-year-old woman with chromosome 22q11.2 deletion syndrome. Her medical history includes a surgically repaired tetralogy of Fallot (a congenital heart defect), mild heart failure, skeletal malformations, autism spectrum disorder, and significant learning and sensory challenges. Despite her needs, she was placed in a regular school, where she faced persistent misunderstanding, bullying, and harassment by a teacher. The healthcare system proved similarly ill-equipped. Because of her medical complexity, particularly her congenital heart disease, multiple psychiatric and adult-care clinics refused to treat her, citing difficulties in managing conditions outside their specialty.

A pivotal change occurred when she was finally referred to a psychiatric department that practiced interdisciplinary care. There, a team of psychiatrists, psychologists, social workers, and a medical liaison conducted a comprehensive assessment and developed a coordinated care plan. With their help, Cocoro began attending a workshop for people with mental disabilities, where she formed supportive peer relationships. Her parents also found support by connecting with other families and later began offering peer support themselves. With this integrated approach, the family’s overall well-being improved, and Cocoro was able to re-engage with her hobbies.

Nevertheless, concerns remain about her access to future cardiac surgery in hospitals without psychiatric services and about the long-term sustainability of Cocoro’s care as her parents age. Her case highlights three main problems caused by compartmentalized care: care was split across medical specialties with no single team taking overall responsibility; her treatment became disjointed when she moved from children to adult health services; and the healthcare system focused only on her as a patient, while overlooking her caregivers.

To dismantle these barriers, the researchers propose three key systemic reforms. First, they call for changes in medical education to help clinicians recognize and address compartmentalization. Second, they emphasize ensuring continuity of care as patients transition from childhood to adulthood, particularly for those with complex, long-term conditions. Third, they call for wider changes to the healthcare system to remove structural obstacles, particularly for people with multiple long-term conditions who are most harmed by fragmented care.

As medical care becomes more fragmented, these cases highlight the need for policies and services to reconsider current practices and move toward more inclusive healthcare systems. As Prof. Kasai emphasizes, “The central message is the need to reconsider vertically segmented medical systems and to promote medical practice and medical education that ensure that no one is left behind.”

........

 

The article, “Medical Compartmentalisation: A Patient with Chromosome 22q11.2 Deletion Syndrome in Japan,” was published in the journal The Lancet at DOI: 10.1016/S0140-6736(25)02267-6

Funding information

This work was supported by JSPS KAKENHI grant numbers JP21H05171 (to Kiyoto Kasai), JP21H05174 (to Kiyoto Kasai and Junko Kitanaka), JP21H05175 (to Shin-ichiro Kumagaya), and JP23H02834 (to Kiyoto Kasai); AMED grant number 20ek0109369 and JP25oa0439005h0001; UTokyo Institute for Diversity and Adaptation of Human Mind (to Kiyoto Kasai); and the International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (to Kiyoto Kasai).

International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo

 The IRCN was established at the University of Tokyo in 2017, as a research center under the WPI program to tackle the ultimate question, “How does human intelligence arise?” The IRCN aims to (1) elucidate fundamental principles of neural circuit maturation, (2) understand the emergence of psychiatric disorders underlying impaired human intelligence, and (3) drive the development of next-generation artificial intelligence based on these principles and function of multimodal neuronal connections in the brain.

Find out more at: https://ircn.jp/en/

About the World Premier International Research Center Initiative (WPI) 

The WPI program was launched in 2007 by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT) to foster globally visible research centers boasting the highest standards and outstanding research environments. Operating at institutions throughout Japan, the 18 centers that have been adopted are given a high degree of autonomy, allowing them to engage in innovative modes of management and research. The program is administered by the Japan Society for the Promotion of Science (JSPS).

See the latest research news from the centers at the WPI News Portal: https://www.eurekalert.org/newsportal/WPI

Main WPI program site: www.jsps.go.jp/english/e-toplevel

About Professor Kiyoto Kasai from the University of Tokyo, Japan

Professor Kiyoto Kasai, M.D., Ph.D., is a Professor of Neuropsychiatry at the University of Tokyo School of Medicine, where he leads research at the Center for Brain Imaging in Health and Disease. A board-certified psychiatrist, his distinguished career includes clinical training in Japan and a visiting instructorship at Harvard Medical School. His research integrates neuroimaging and clinical psychiatry to elucidate brain pathology in disorders, such as schizophrenia, with a dedicated focus on developing early intervention and rehabilitation strategies to improve long-term patient outcomes within the community.

 

Exploring marine-derived compounds as potential anti-cancer agents: mechanisms and therapeutic implications





Chinese Medical Journals Publishing House Co., Ltd.




Marine-derived compounds have emerged as a promising frontier in cancer research due to their remarkable structural diversity and broad-spectrum bioactivities. The marine environment, encompassing diverse organisms (e.g., sponges, algae, tunicates, mollusks, and marine microbes), is a prolific source of novel bioactive molecules with potent anti-cancer properties. Key classes of these compounds include alkaloids, polysaccharides, peptides, terpenoids, and polyketides, which exert anti-tumor effects through diverse mechanisms, including the induction of apoptosis, inhibition of angiogenesis, modulation of immune responses, interference with cell cycle progression, and targeting of critical signaling pathways involved in tumorigenesis and metastasis. Notably, marine-derived drugs such as trabectedin, eribulin, and plitidepsin have received regulatory approval for the treatment of various malignancies, demonstrating the translational potential of these natural compounds. Ongoing clinical and preclinical investigations to explore a wide range of marine metabolites for their cytotoxic, anti-proliferative, and chemosensitizing properties. Advances in marine biotechnology, including genome mining, synthetic biology, and fermentation technologies, have significantly facilitated the discovery, sustainable production, and structural optimization of marine natural products. However, challenges such as low yield, structural complexity, limited water solubility, and poor bioavailability hinder their broader clinical application. The integration of novel drug delivery systems—such as nanoparticles, liposomes, and conjugates—offers a viable solution to overcome these limitations and improve pharmacokinetic profiles. This review provides a comprehensive overview of the mechanisms of action, therapeutic applications, and clinical development of marine-derived anti-cancer compounds. It also emphasizes the need for deeper insights into their molecular targets and the potential for synergistic use with existing chemotherapeutic agents. Future directions should focus on exploring untapped marine biodiversity, developing eco-friendly harvesting strategies, and innovative delivery platforms to fully harness the therapeutic promise of the marine pharmacopeia in oncology.

Corals’ boldest cousins: UH scientists discover marine creatures bending the laws of evolution



Pensoft Publishers
Sibling zoantharians from the Indo-Pacific (A) and the Atlantic (B) oceans. 

image: 

Sibling zoantharians from the Indo-Pacific (A) and the Atlantic (B) oceans. 

view more 

Credit: Dr. Maria “Duda” Santos.





KĀNEʻOHE, HI [Jan 30]— In the realm of marine biogeography, there is a widely held scientific principle: the Atlantic and Indo-Pacific oceans are worlds apart. If you dive in Brazil and then in Okinawa, you expect to see entirely different groups of fish and coral. But according to a new global study published today in Frontiers of Biogeography, one group of colorful hexacorals, anemone-like creatures—known as zoantharians—is breaking all the rules.

The study, led by Dr. Maria “Duda” Santos of the UH Mānoa Hawaiʻi Institute of Marine Biology (HIMB) ToBo Lab and the University of the Ryukyus, began with a moment of "déjà vu" underwater. 

"During my first dive in Okinawa, I was surrounded by a multitude of species I had never seen in my homeland of Brazil.  But then I saw the zoantharians. They looked exactly like the ones back home—the same colors, shapes, and sizes. It was striking."

-  shares Dr. Santos.

While the Indo-Pacific typically hosts ten times the species diversity of the Atlantic for most reef animals, this research found that the genetic and morphological divergence between oceans for these creatures is surprisingly narrow.

The Secrets of the Ultimate Travelers

The researchers suggest that zoantharians may be the ultimate oceanic travelers. Their secret likely lies in high dispersal via an "epic" larval phase, where young zoantharians can survive in open water for over 100 days, paired with an ability to "raft" across ocean basins by hitchhiking on floating objects. Furthermore, an unusually slow evolutionary rate appears to keep distant populations looking and acting like siblings, even after millions of years of separation by continental barriers.

This discovery has major implications for the future of our oceans. As climate change stresses traditional stony corals, zoantharians are increasingly moving in to fill the void. 

"In habitats impacted by stress, some zoantharian species can outcompete stony corals. We are seeing 'phase shifts' where reefs once dominated by corals are being taken over by zoantharians. Understanding how they spread helps us forecast what the reefs of the future will look like."

- explains Dr. Santos.

A Global Atlas for a Changing Ocean

This landmark study represents a massive international effort, uniting a team from Hawai’i, Okinawa, Russia, Brazil, Hong Kong, Taiwan, and Indonesia. By combining DNA data and records from Mexico to the Philippines, the team has provided the first-ever global "atlas" for a group of animals that has remained in the shadows of their more famous coral cousins for decades. This map of the past and present provides a vital baseline for monitoring how marine life will navigate a warming world.

 

Original source: 

Santos, M.E.A., Kise, H., Fourreau, C.J.L., Kiriukhin, B., Kitahara, M.V., Baker, D.M., Toonen, R.J., Liu, P.J., Chang, A., Tu, T.-H., Widiastuti, Agustini, K.M.P., Bowen, B.W. and Reimer, J.D. (2026). Global biogeography of zoantharians indicates a weak genetic differentiation between the Atlantic and Indo-Pacific oceans, and distinct communities in tropical and temperate provinces. Frontiers of Biogeography, 19. doi:https://doi.org/10.21425/fob.19.174247.

***

About Hawaiʻi Institute of Marine Biology

Established in 1951, the Hawaiʻi Institute of Marine Biology (HIMB) is a global center where marine science connects cutting-edge research, transformative education, and community engagement. Located on the storied islet of Moku o Loʻe, steeped in Hawaiian culture, and surrounded by a living coral reef in Kāneʻohe Bay, HIMB is comprised of more than 200 passionate faculty, postdocs, students, and staff who study and help steward all aspects of ocean life, from microbes to marine mammals. As a research unit at the University of Hawaiʻi at Mānoa, which is a Native Hawaiian Place of Learning, HIMB embraces diverse ways of knowing to understand and steward the world’s oceans.

About the Toonen-Bowen “ToBo” Lab at HIMB 

HIMB’s ToBo Lab focuses on understanding patterns of marine biodiversity in the service of conservation, by studying the genetics and ecology of a wide variety of marine species. The ToBo Lab is shared by two Principal Investigators: Robert J. Toonen and Brian Bowen. Toonen’s research focuses on the processes that influence dispersal and recruitment in coastal marine invertebrates, and the evolutionary consequences of larval developmental modes. Bowen’s research program is focused on the biogeography, evolution, and dispersal of marine vertebrates with a focus on coral reef fishes. Toonen and Bowen share ongoing programs that document the marine ecology, evolution, and biodiversity of the Hawaiian Archipelago.

 Underwater view in a Malaysian coral reef with Duda searching for zoantharian species. 

Underwater view in a Malaysian coral reef with Duda searching for zoantharian species. 

Credit

Sam Webster

 

Cultivated peanut AhPR10 gene family mediates resistance to Aspergillus flavus




KeAi Communications Co., Ltd.

Fig. 1. Expression of recombinant AhPR10-33 in Escherichia coli and analysis of its nuclease activity and inhibitory effects on Aspergillus flavus growth 

image: 

Fig. 1. Expression of recombinant AhPR10-33 in Escherichia coli and analysis of its nuclease activity and inhibitory effects on Aspergillus flavus growth

view more 

Credit: Zhao Q, et al.




Pathogenesis-related (PR) proteins comprise a group of proteins synthesized by plants in response to biotic and abiotic stress. In particular, the PR10 family (nuclease activity) represents the largest PR protein subfamily and plays a vital role in plant growth, development, and stress responses.

In a new study published in the Journal of Integrative Agriculture, a team of researchers from China identified and analyzed PR10 genes in cultivated peanut (Arachis hypogaea L.), examining their phylogenetic relationships, conserved motifs, gene structures, and syntenic relationships.

“The analysis identified 54 AhPR10 genes, which were classified into eight groups based on phylogenetic relationships, supported by gene structure and conserved motif characterization,” shares corresponding author Xinyou Zhang, an academician and professor at Henan Academy of Agricultural Sciences. “Analysis of chromosomal distribution and synteny demonstrated that segmental duplications played a crucial role in the expansion of the AhPR10 gene family.  The identified AhPR10 genes exhibited both constitutive and inducible expression patterns.”

Notably, AhPR10-7AhPR10-33, and AhPR10-41 demonstrated potential importance in peanut resistance to Aspergillus flavus.

In vitro fungistatic experiments demonstrated that recombinant AhPR10-33 effectively inhibited Aflavus mycelial growth,” adds co-corresponding author Suoyi Han, a professor at Henan Academy of Agricultural Sciences. “These findings provide valuable insights for future investigations into AhPR10 functions in protecting peanut from Aflavus infection.”

###

Contact the author: Correspondence Xinyou Zhang, E-mail: haasxinyou@163.com; Suoyi Han, E-mail: suoyi_han@126.com

The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).